IP Verse

Cd33 Specific Chimeric Antigen Receptors For Cancer Immunotherapy - EP3126390

PATENT ANALYSIS

Patent Details

Grant Date
Oct 16, 2019
Company
CELLECTIS
Oppositions

WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB

More patents of Cellectis

EP2997141

EP3116902

EP3189073

Want to monitor this patent?

Feel free to send us a message here and we will get back to you